SFX by Ex Libris Inc.

Title:	Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission
Source:	Science [0036-8075] Derdeyn, C A yr:2004

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Wei, George M M. "Antibody neutralization and escape by HIV-1." Nature 422.6929 (2003): 307-312.
description	2.	Wu, X. "Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant." Journal of virology 80.2: 835-844.
description	3.	Harrison, Lee H B. "Behavioral impact, acceptability, and HIV incidence among homosexual men with access to postexposure chemoprophylaxis for HIV." Journal of acquired immune deficiency syndromes 35.5 (2004): 519-25.
description	4.	Chohan, B. "Selection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels." Journal of virology 79.10 (2005): 6528-31.
description	5.	Busch, Richard P. "Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection." AIDS 17.13 (2003): 1871-9.
description	6.	Wyatt, Richard T T. "HIV vaccine design and the neutralizing antibody problem." Nature immunology 5.3 (2004): 233-6.
description	7.	Kwong, Peter D D. "HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites." Nature 420.6916 (2003): 678-82.
description	8.	Wyatt, R. "The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens." Science 280.5371 (1998): 1884-8.
description	9.	Burton, T. "Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1." Journal of virology 77.19 (2003): 10557-65.
description	10.	Groopman, L I E. "Haematologic manifestations of the human immune deficiency virus (HIV)." British journal of haematology 66.2 (1987): 251-256.
description	11.	Arthos, J. "HIV-1 envelope protein binds to and signals through integrin alpha4beta7, the gut mucosal homing receptor for peripheral T cells." Nature immunology 9.3 (2008): 301-9.
description	12.	Montano, M A A. "Dysregulation through the NF-kappaB enhancer and TATA box of the human immunodeficiency virus type 1 subtype E promoter." Journal of virology 72.10 (1998): 8446-52.
description	13.	Hessell, Ann J J. "Fc receptor but not complement binding is important in antibody protection against HIV." Nature 449.7158 (2007): 101-4.
description	14.	Wand, H. "Increasing HIV transmission through male homosexual and heterosexual contact in Australia: Results from an extended back-projection approach." HIV medicine 11.6 (2010): 395-403.
description	15.	Meyer, T. "Repeated detection of lymphogranuloma venereum caused by Chlamydia trachomatis L2 in homosexual men in Hamburg [2]." Sexually transmitted infections 81.1 (2005): 91-92.
description	16.	Morton, W R R. "Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment." Journal of virology 72.5 (1998): 4265-73.
description	17.	Pancera, M. "Selective recognition of oligomeric HIV-1 primary isolate envelope glycoproteins by potently neutralizing ligands requires efficient precursor cleavage." Virology 332.1 (2005): 145-56.
description	18.	Pinter, A. "The V1/V2 domain of gp120 is a global regulator of the sensitivity of primary human immunodeficiency virus type 1 isolates to neutralization by antibodies commonly induced upon infection." Journal of virology 78.10 (2004): 5205-15.
description	19.	Martin, Jeffrey N N. "Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behavior." AIDS 18.5 (2004): 787-92.
description	20.	Obadia, Y. "Knowledge of HIV postexposure prophylaxis in a population of HIV-positive outpatients: results of a French national survey." Journal of acquired immune deficiency syndromes (2004): 393-400.